Artykuły w czasopismach na temat „Anti-HCoV-229E activity”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 40 najlepszych artykułów w czasopismach naukowych na temat „Anti-HCoV-229E activity”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Hakem, Asma, Lowiese Desmarets, Ramla Sahli, Rawen Ben Malek, Charline Camuzet, Nathan François, Gabriel Lefèvre i in. "Luteolin Isolated from Juncus acutus L., a Potential Remedy for Human Coronavirus 229E". Molecules 28, nr 11 (23.05.2023): 4263. http://dx.doi.org/10.3390/molecules28114263.
Pełny tekst źródłaParang, Keykavous, Naglaa Salem El-Sayed, Assad J. Kazeminy i Rakesh K. Tiwari. "Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)". Molecules 25, nr 10 (17.05.2020): 2343. http://dx.doi.org/10.3390/molecules25102343.
Pełny tekst źródłaChang, Fang-Rong, Chiao-Ting Yen, Mohamed EI-Shazly, Wen-Hsun Lin, Ming-Hong Yen, Kuei-Hsiang Lin i Yang-Chang Wu. "Anti-Human Coronavirus (anti-HCoV) Triterpenoids from the Leaves of Euphorbia Neriifolia". Natural Product Communications 7, nr 11 (listopad 2012): 1934578X1200701. http://dx.doi.org/10.1177/1934578x1200701103.
Pełny tekst źródłaKwon, Eun-Bin, Buyun Kim, Young Soo Kim i Jang-Gi Choi. "Anastrozole Protects against Human Coronavirus Infection by Ameliorating the Reactive Oxygen Species–Mediated Inflammatory Response". Antioxidants 13, nr 1 (17.01.2024): 116. http://dx.doi.org/10.3390/antiox13010116.
Pełny tekst źródłaAl Mosawi, AJ. "Remdesivir Research Progress: An Overview of the Emerging Evidence". Journal of Biomedical Research & Environmental Sciences 1, nr 6 (14.10.2020): 216–18. http://dx.doi.org/10.37871/jbres1146.
Pełny tekst źródłaBuchowicz, Włodzimierz, i Mariola Koszytkowska-Stawińska. "How Much Potential Do Nucleoside Analogs Offer to Combat Human Corona Viruses?" Organics 5, nr 2 (8.05.2024): 71–110. http://dx.doi.org/10.3390/org5020006.
Pełny tekst źródłaChen, Lili, Chunshan Gui, Xiaomin Luo, Qingang Yang, Stephan Günther, Elke Scandella, Christian Drosten i in. "Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro". Journal of Virology 79, nr 11 (1.06.2005): 7095–103. http://dx.doi.org/10.1128/jvi.79.11.7095-7103.2005.
Pełny tekst źródłaPasquereau, Sébastien, Zeina Nehme, Sandy Haidar Ahmad, Fadoua Daouad, Jeanne Van Assche, Clémentine Wallet, Christian Schwartz, Olivier Rohr, Stéphanie Morot-Bizot i Georges Herbein. "Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro". Viruses 13, nr 2 (23.02.2021): 354. http://dx.doi.org/10.3390/v13020354.
Pełny tekst źródłaLan, Qiaoshuai, Chao Wang, Jie Zhou, Lijue Wang, Fanke Jiao, Yanbo Zhang, Yanxing Cai, Lu Lu, Shuai Xia i Shibo Jiang. "25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses". International Journal of Molecular Sciences 22, nr 21 (1.11.2021): 11869. http://dx.doi.org/10.3390/ijms222111869.
Pełny tekst źródłaSong, Yabin, Yongqiang Deng, Huiqiang Wang, Zhuchun Bei, Hongjing Gu, Hui Zhao, Hong Wang i in. "Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro". Molecules 27, nr 3 (21.01.2022): 712. http://dx.doi.org/10.3390/molecules27030712.
Pełny tekst źródłaLiu, Weiyong, Min Zhang, Chengxiu Hu, Huijuan Song, Yi Mei, Yingle Liu i Qi Zhang. "Remdesivir Derivative VV116 Is a Potential Broad-Spectrum Inhibitor of Both Human and Animal Coronaviruses". Viruses 15, nr 12 (23.11.2023): 2295. http://dx.doi.org/10.3390/v15122295.
Pełny tekst źródłaTusell, Sonia M., Stephanie A. Schittone i Kathryn V. Holmes. "Mutational Analysis of Aminopeptidase N, a Receptor for Several Group 1 Coronaviruses, Identifies Key Determinants of Viral Host Range". Journal of Virology 81, nr 3 (8.11.2006): 1261–73. http://dx.doi.org/10.1128/jvi.01510-06.
Pełny tekst źródłaCalistri, Arianna, Anna Luganini, Barbara Mognetti, Elizabeth Elder, Giulia Sibille, Valeria Conciatori, Claudia Del Vecchio i in. "The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses". Microorganisms 9, nr 8 (14.08.2021): 1731. http://dx.doi.org/10.3390/microorganisms9081731.
Pełny tekst źródłaBege, Miklós, Alexandra Kiss, Ilona Bereczki, Jan Hodek, Lenke Polyák, Gábor Szemán-Nagy, Lieve Naesens, Jan Weber i Anikó Borbás. "Synthesis and Anticancer and Antiviral Activities of C-2′-Branched Arabinonucleosides". International Journal of Molecular Sciences 23, nr 20 (19.10.2022): 12566. http://dx.doi.org/10.3390/ijms232012566.
Pełny tekst źródłaShahhamzehei, Nasim, Sara Abdelfatah i Thomas Efferth. "In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library". Pharmaceuticals 15, nr 3 (3.03.2022): 308. http://dx.doi.org/10.3390/ph15030308.
Pełny tekst źródłaAmbrosino, Annalisa, Annalisa Chianese, Carla Zannella, Simona Piccolella, Severina Pacifico, Rosa Giugliano, Gianluigi Franci i in. "Galdieria sulphuraria: An Extremophilic Alga as a Source of Antiviral Bioactive Compounds". Marine Drugs 21, nr 7 (28.06.2023): 383. http://dx.doi.org/10.3390/md21070383.
Pełny tekst źródłaObermann, Wiebke, Alexandra Friedrich, Ramakanth Madhugiri, Paul Klemm, Jan Philipp Mengel, Torsten Hain, Stephan Pleschka i in. "Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity". Viruses 14, nr 3 (3.03.2022): 519. http://dx.doi.org/10.3390/v14030519.
Pełny tekst źródłaAl Ibrahim, Malak, Zachee Louis Evariste Akissi, Lowiese Desmarets, Gabriel Lefèvre, Jennifer Samaillie, Imelda Raczkiewicz, Sevser Sahpaz i in. "Discovery of Anti-Coronavirus Cinnamoyl Triterpenoids Isolated from Hippophae rhamnoides during a Screening of Halophytes from the North Sea and Channel Coasts in Northern France". International Journal of Molecular Sciences 24, nr 23 (22.11.2023): 16617. http://dx.doi.org/10.3390/ijms242316617.
Pełny tekst źródłaShishkova, Kalina, Antoniya Stoymirska, Radoslav Chayrov, Stoyan Shishkov, Hristina Sbirkova-Dimitrova, Rusi Rusew, Boris Shivachev i Ivanka Stankova. "Amantadine and Rimantadine Analogues—Single-Crystal Analysis and Anti-Coronaviral Activity". Crystals 13, nr 9 (14.09.2023): 1374. http://dx.doi.org/10.3390/cryst13091374.
Pełny tekst źródłaAndreu, Sabina, Inés Ripa, Raquel Bello-Morales i José Antonio López-Guerrero. "Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro". Viruses 15, nr 4 (15.04.2023): 972. http://dx.doi.org/10.3390/v15040972.
Pełny tekst źródłaPiacentini, Sara, Anna Riccio, Silvia Santopolo, Silvia Pauciullo, Simone La Frazia, Antonio Rossi, Jean-Francois Rossignol i M. Gabriella Santoro. "The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein". Frontiers in Microbiology 14 (29.08.2023). http://dx.doi.org/10.3389/fmicb.2023.1206951.
Pełny tekst źródłaCai, Yanxing, Wei Xu, Jiayi Tang, Najing Cao, Qiaoshuai Lan, Lu Lu i Shibo Jiang. "A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses". Cell & Bioscience 11, nr 1 (8.07.2021). http://dx.doi.org/10.1186/s13578-021-00638-w.
Pełny tekst źródłaElango, Abinaya. "In-vitro Assessment of Antiviral Activity of the Herbo Mineral Capsule, Fema SakthiTM, against Human Coronavirus (HCoV) on VERO Cells". Journal of Communicable Diseases, 16.03.2022, 120–23. http://dx.doi.org/10.24321/0019.5138.202219.
Pełny tekst źródłaBai, Xiyuan, Ashley M. Buckle, Eszter K. Vladar, Edward N. Janoff, Reeti Khare, Diane Ordway, David Beckham i in. "Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19". Scientific Reports 12, nr 1 (25.03.2022). http://dx.doi.org/10.1038/s41598-022-09133-9.
Pełny tekst źródłaHegazy, Ghada E., Marwa M. Abu-Serie, Nadia A. Soliman, Mohamed Teleb i Yasser R. Abdel-Fattah. "Superior anti-pulmonary viral potential of Natrialba sp. M6-producing surfactin and C50 carotenoid pigment with unveiling its action modes". Virology Journal 20, nr 1 (30.10.2023). http://dx.doi.org/10.1186/s12985-023-02215-8.
Pełny tekst źródłaPasquereau, Sébastien, Mathilde Galais, Maxime Bellefroid, Irene Pachón Angona, Stéphanie Morot-Bizot, Lhassane Ismaili, Carine Van Lint i Georges Herbein. "Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro". Scientific Reports 12, nr 1 (24.11.2022). http://dx.doi.org/10.1038/s41598-022-24682-9.
Pełny tekst źródłaSingh, Prachi, Ardra P, Hariprasad V.R., Babu U.V., Mohamed Rafiq i Raghavendra Pralhada Rao. "Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin-Like Main Protease (3CLpro) from Four Different Coronaviruses-: An in-silico Approach". Coronaviruses 02 (16.02.2021). http://dx.doi.org/10.2174/2666796702666210216142508.
Pełny tekst źródłaSharwani, Khalid, Ravi Sharma, Madhan Krishnan, Terry Jones, Martin Mayora-Neto, Diego Cantoni, Nigel A. Temperton i in. "Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples". Journal of Infectious Diseases, 23.06.2021. http://dx.doi.org/10.1093/infdis/jiab333.
Pełny tekst źródłaShapira, Tirosh, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Peña-Díaz, Grace Jordana, William Rees i in. "Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication". Molecular Biomedicine 3, nr 1 (12.12.2022). http://dx.doi.org/10.1186/s43556-022-00111-1.
Pełny tekst źródłaZhang, Yumin, Yuan Sun, Yuanchao Xie, Weijuan Shang, Zhen Wang, Hualiang Jiang, Jingshan Shen, Gengfu Xiao i Leike Zhang. "A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir". Signal Transduction and Targeted Therapy 8, nr 1 (22.09.2023). http://dx.doi.org/10.1038/s41392-023-01587-1.
Pełny tekst źródłaKirby, Emily N., Xavier B. Montin, Timothy P. Allen, Jaslan Densumite, Brooke N. Trowbridge i Michael R. Beard. "CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function". Innate Immunity, 23.01.2024. http://dx.doi.org/10.1177/17534259231225611.
Pełny tekst źródłaYuan, Shuofeng, Xiaopan Gao, Kaiming Tang, Jian-Piao Cai, Menglong Hu, Peng Luo, Lei Wen i in. "Targeting papain-like protease for broad-spectrum coronavirus inhibition". Protein & Cell, 6.04.2022. http://dx.doi.org/10.1007/s13238-022-00909-3.
Pełny tekst źródłaMorin-Dewaele, Margot, Sophie Bartier, François Berry, Rozenn Brillet, Dennis Salomón López-Molina, Công Trung Nguyễn, Pascale Maille i in. "Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry". Scientific Reports 12, nr 1 (6.12.2022). http://dx.doi.org/10.1038/s41598-022-25399-5.
Pełny tekst źródłaSandler, Zachary J., Mason R. Firpo, Oreoluwa S. Omoba, Michelle N. Vu, Vineet D. Menachery i Bryan C. Mounce. "Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening". Antimicrobial Agents and Chemotherapy 64, nr 6 (13.04.2020). http://dx.doi.org/10.1128/aac.00086-20.
Pełny tekst źródłaYang, Minghui, Chunhui Li, Guoguo Ye, Chenguang Shen, Huiping Shi, Liping Zhong, Yuxin Tian i in. "Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity". Signal Transduction and Targeted Therapy 9, nr 1 (14.02.2024). http://dx.doi.org/10.1038/s41392-024-01748-w.
Pełny tekst źródłaZhao, Xu, Zhihui Cao, Xiufu Hua, Luocheng Chen, Tong Wei i Shaozhen Li. "Silver molybdate nanocrystal-reinforced high-performance anti-coronavirus composite polymer coating". AIP Advances 13, nr 10 (1.10.2023). http://dx.doi.org/10.1063/5.0163736.
Pełny tekst źródłaRodríguez-Pulido, Miguel, Eva Calvo-Pinilla, Miryam Polo, Juan-Carlos Saiz, Raúl Fernández-González, Eva Pericuesta, Alfonso Gutiérrez-Adán, Francisco Sobrino, Miguel A. Martín-Acebes i Margarita Sáiz. "Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses". Frontiers in Immunology 14 (29.03.2023). http://dx.doi.org/10.3389/fimmu.2023.1166725.
Pełny tekst źródłaBahgat, Dina M., Haidy A. Gad, Eman Al-Sayed, Sara H. Mahmoud, Ahmed Mostafa, Nadia M. Mahfouz, Omayma A. Eldahshan i Abdel Nasser B. Singab. "Essential Oil of Cestrum diurnum L.: GC/MS Analysis, in vitro and in silico Anti‐HCoV‐229E Effects and Inhibitory Activity against LPS‐Induced Inflammation". Chemistry & Biodiversity, 22.02.2023. http://dx.doi.org/10.1002/cbdv.202201045.
Pełny tekst źródłaLeón-Gutiérrez, Gabriela, James Edward Elste, Carlos Cabello-Gutiérrez, Cesar Millán-Pacheco, Mario H. Martínez-Gómez, Rafael Mejía-Alvarez, Vaibhav Tiwari i Armando Mejía. "A potent virucidal activity of functionalized TiO2 nanoparticles adsorbed with flavonoids against SARS-CoV-2". Applied Microbiology and Biotechnology, 11.08.2022. http://dx.doi.org/10.1007/s00253-022-12112-9.
Pełny tekst źródłaSaiz, Maria Laura, Marta L. DeDiego, Darío López-García, Viviana Corte-Iglesias, Aroa Baragaño Raneros, Ivan Astola, Victor Asensi, Carlos López-Larrea i Beatriz Suarez-Alvarez. "Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity". Clinical Epigenetics 13, nr 1 (11.10.2021). http://dx.doi.org/10.1186/s13148-021-01168-5.
Pełny tekst źródła